3Scan Raises $6.67 Million from Lux Capital, Dolby Ventures for New Technologies to Transform Pathology

Business News
Print
SAN FRANCISCO--(BUSINESS WIRE)--3Scan, (www.3scan.com), developer of transformative technologies for pathology and a revolutionary new Knife Edge Scanning Microscope (KESM) for powerful, rapid diagnostic and therapeutic discovery applications, announced today that it has closed a Series A fundraising round of $6.7 million. The financing, led by Lux Capital will support the continued development and deployment of 3Scan’s KESM technology. "While medical science has made incredible advances in rec

imageimage
image

Read more